VACONTIL Tablet Ref.[28044] Active ingredients: Loperamide

Source: Υπουργείο Υγείας (CY)  Revision Year: 2019  Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street 3011, Cyprus

4.1. Therapeutic indications

Symptomatic treatment of acute diarrhoea in adults and children aged 12 years and over.

Symptomatic treatment of acute episodes of diarrhoea associated with irritable bowel syndrome in adults aged 18 years and over following initial diagnosis by a doctor.

4.2. Posology and method of administration

Posology

Acute diarrhoea

Adults and children 12 years and over

Two tablets (4 mg) initially, and one tablet (2 mg) after each loose stool. The usual dose is 3 to 4 tablets a day. The total daily dose should not exceed 6 tablets (12 mg).

Symptomatic treatment of acute episodes of diarrhoea associated with irritable bowel syndrome in adult aged 18 years and over

The recommended doses is two (4 mg) tablets to be taken initially, followed by 1 tablet (2 mg) after every loose stool, or as previously advised by your doctor. The maximum daily dose should not exceed 6 tablets daily.

Paediatric population

Loperamide is contraindicated in children less than 12 years of age.

Elderly

No dose adjustment is required for the elderly.

Hepatic impairment

Although no pharmacokinetic data are available in patients with hepatic impairment, loperamide should be used with caution in such patients because of reduced first pass metabolism (see section 4.4).

Renal impairment

No dose adjustment is required for patients with renal impairment.

Method of administration

Oral use.

The tablets should be taken with liquid.

4.9. Overdose

Symptoms

In case of overdose (including relative overdose due to hepatic dysfunction), CNS depression (stupor, coordination abnormality, somnolence, miosis, muscular hypertonia and respiratory depression), constipation, urinary retention, ileus may occur. Children and patients with hepatic dysfunction may be more sensitive to CNS effects.

In individuals who have ingested overdoses of loperamide HCl, cardiac events such as QT interval and QRS complex prolongation, torsades de pointes, other serious ventricular arrhythmias, cardiac arrest and syncope have been observed (see section 4.4). Fatal cases have also been reported. Overdose can unmask existing Brugada syndrome.

Treatment

In cases of overdose, ECG monitoring for QT interval prolongation should be initiated.

If CNS symptoms of overdose occur, naloxone may be given as an antidote. Since the duration of action of loperamide is longer than that of naloxone (1 to 3 hours), repeated treatment with naloxone might be indicated. Therefore, the patient should be monitored closely for at least 48 hours in order to detect possible CNS depression.

6.3. Shelf life

5 years.

6.4. Special precautions for storage

Store below 25ºC, in the original package, in order to protect from light and moisture.

6.5. Nature and contents of container

Combination blisters of polyvinylchloride film and aluminium foil. Blisters with a patient information leaflet are inserted in a carton.

Cartons containing 10 or 20 tablets are available.

Cartons containing 40, 100, 500 or 1000 tablets are available.

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

Not applicable.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.